Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 40541 - 40560 out of 566329 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L04AG12) ofatumumab (adm: P) | Kesimpta 20 mg/0.4 mL injection, 0.4 mL pen device | Solution for injection 20 mg in 0.4 mL pre-filled pen, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L04AG12) ofatumumab (adm: P) | Kesimpta 20 mg/0.4 mL injection, 0.4 mL pen device | Solution for injection 20 mg in 0.4 mL pre-filled pen, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L04AG14) ublituximab | Briumvi 150 mg/6 mL injection, 6 mL vial | Solution concentrate for I.V. infusion 150 mg in 6 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Multiple Sclerosis | NEURAXPHARMAUSTRALIAPTYLIMITED |
| Australia | (L04AG14) ublituximab | Briumvi 150 mg/6 mL injection, 6 mL vial | Solution concentrate for I.V. infusion 150 mg in 6 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Multiple Sclerosis | NEURAXPHARMAUSTRALIAPTYLIMITED |
| Australia | (L04AG14) ublituximab | Briumvi 150 mg/6 mL injection, 6 mL vial | Solution concentrate for I.V. infusion 150 mg in 6 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Multiple Sclerosis | NEURAXPHARMAUSTRALIAPTYLIMITED |
| Australia | (L04AG14) ublituximab | Briumvi 150 mg/6 mL injection, 6 mL vial | Solution concentrate for I.V. infusion 150 mg in 6 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Multiple Sclerosis | NEURAXPHARMAUSTRALIAPTYLIMITED |
| Australia | (L04AG14) ublituximab | Briumvi 150 mg/6 mL injection, 6 mL vial | Solution concentrate for I.V. infusion 150 mg in 6 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Multiple Sclerosis | NEURAXPHARMAUSTRALIAPTYLIMITED |
| Australia | (L04AG14) ublituximab | Briumvi 150 mg/6 mL injection, 6 mL vial | Solution concentrate for I.V. infusion 150 mg in 6 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Multiple Sclerosis | NEURAXPHARMAUSTRALIAPTYLIMITED |
| Australia | (L04AG14) ublituximab | Briumvi 150 mg/6 mL injection, 6 mL vial | Solution concentrate for I.V. infusion 150 mg in 6 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Multiple Sclerosis | NEURAXPHARMAUSTRALIAPTYLIMITED |
| Australia | (L04AG14) ublituximab | Briumvi 150 mg/6 mL injection, 6 mL vial | Solution concentrate for I.V. infusion 150 mg in 6 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Multiple Sclerosis | NEURAXPHARMAUSTRALIAPTYLIMITED |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 1 mg/mL oral liquid, 60 mL | Oral solution 1 mg per mL, 60 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | PfizerAustraliaPtyLtd |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 1 mg/mL oral liquid, 60 mL | Oral solution 1 mg per mL, 60 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | PfizerAustraliaPtyLtd |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 1 mg/mL oral liquid, 60 mL | Oral solution 1 mg per mL, 60 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | PfizerAustraliaPtyLtd |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 1 mg/mL oral liquid, 60 mL | Oral solution 1 mg per mL, 60 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | PfizerAustraliaPtyLtd |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 1 mg/mL oral liquid, 60 mL | Oral solution 1 mg per mL, 60 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | PfizerAustraliaPtyLtd |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 1 mg/mL oral liquid, 60 mL | Oral solution 1 mg per mL, 60 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | PfizerAustraliaPtyLtd |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 1 mg/mL oral liquid, 60 mL | Oral solution 1 mg per mL, 60 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | PfizerAustraliaPtyLtd |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 1 mg/mL oral liquid, 60 mL | Oral solution 1 mg per mL, 60 mL, 1 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | PfizerAustraliaPtyLtd |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 1 mg/mL oral liquid, 60 mL | Oral solution 1 mg per mL, 60 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | PfizerAustraliaPtyLtd |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 1 mg/mL oral liquid, 60 mL | Oral solution 1 mg per mL, 60 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | PfizerAustraliaPtyLtd |
Pages
